-+ 0.00%
-+ 0.00%
-+ 0.00%

Nestlé Sees 'Huge Opportunity' in Rise of GLP-1 Weight-loss Drugs

MT Newswires·08/17/2026 10:19:29
Listen to the news
10:19 AM EDT, 08/17/2026 (MT Newswires) -- Nestlé (NESN.SW) sees the growing use of GLP-1 weight-loss drugs as a "huge opportunity" for the company, Reuters reported Monday, citing its chief technology officer. Stefan Palzer said the Swiss food giant is using artificial intelligence and other technologies to analyze clinical research, identify nutrient combinations, and develop products for consumers taking medicines like Ozempic and Wegovy.